المؤلفون: Kugelberg, E, Norstrom, T, Petersen, TK, Duvold, T, Andersson, DI, Hughes, D

المصدر: Antimicrobial agents and chemotherapy. 49(8):3435-3441

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:1933111

المؤلفون: Ortner VK; Department of Dermatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark., Kilov K; Studies&Me A/S, Copenhagen, Denmark., Mondragón AC; Studies&Me A/S, Copenhagen, Denmark., Fredman G; Department of Dermatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark., Omland SH; Department of Dermatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark., Manole I; Studies&Me A/S, Copenhagen, Denmark.; 2nd Department of Dermatology, Colentina Clinical Hospital, Bucharest, Romania., Laugesen CAP; Studies&Me A/S, Copenhagen, Denmark., Havsager S; Studies&Me A/S, Copenhagen, Denmark., Johansen B; Coegin Pharma AB, Lund, Sweden.; Department of Biology, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Duvold T; Coegin Pharma AB, Lund, Sweden., Isberg AP; Studies&Me A/S, Copenhagen, Denmark., Andersen AD; Studies&Me A/S, Copenhagen, Denmark., Zibert JR; Studies&Me A/S, Copenhagen, Denmark.; Coegin Pharma AB, Lund, Sweden., Hædersdal M; Department of Dermatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

المصدر: Experimental dermatology [Exp Dermatol] 2024 Apr; Vol. 33 (4), pp. e15068.

نوع المنشور: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Munksgaard Country of Publication: Denmark NLM ID: 9301549 Publication Model: Print Cited Medium: Internet ISSN: 1600-0625 (Electronic) Linking ISSN: 09066705 NLM ISO Abbreviation: Exp Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Keratosis, Actinic*/drug therapy , Telemedicine*, Humans ; Blood Proteins ; Skin

المؤلفون: Ortner VK; Department of Dermatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, 2400 Copenhagen, Denmark vinzent.kevin.ortner@regionh.dk., Johansen B; Clinical Operations, Coegin Pharma AB, Lund, Sweden.; Department of Biology, Norwegian University of Science and Technology, Trondheim, Norway., Kilov K; Studies&Me, Copenhagen, Denmark., Castillo Mondragón A; Studies&Me, Copenhagen, Denmark., Duvold T; Clinical Operations, Coegin Pharma AB, Lund, Sweden., Kihl J; Clinical Operations, Coegin Pharma AB, Lund, Sweden., Ashcroft FJ; Clinical Operations, Coegin Pharma AB, Lund, Sweden.; Department of Biology, Norwegian University of Science and Technology, Trondheim, Norway., Feuerherm AJ; Clinical Operations, Coegin Pharma AB, Lund, Sweden.; Department of Biology, Norwegian University of Science and Technology, Trondheim, Norway., Pind Laugesen C; Studies&Me, Copenhagen, Denmark., Marcker Espersen ML; Studies&Me, Copenhagen, Denmark., Manole I; Second Department of Dermatology, Colentina Clinical Hospital, Bucharest, Romania., Isberg AP; Studies&Me, Copenhagen, Denmark., Andersen AD; Studies&Me, Copenhagen, Denmark., Rakvaag E; Studies&Me, Copenhagen, Denmark., Zibert JR; Clinical Operations, Coegin Pharma AB, Lund, Sweden.; Studies&Me, Copenhagen, Denmark., Haedersdal M; Department of Dermatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, 2400 Copenhagen, Denmark.

المصدر: BMJ open [BMJ Open] 2022 Oct 05; Vol. 12 (10), pp. e061012. Date of Electronic Publication: 2022 Oct 05.

نوع المنشور: Clinical Trial Protocol; Journal Article

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE

مواضيع طبية MeSH: Fatty Acids, Omega-3*/adverse effects , Keratosis, Actinic*/drug therapy , Phospholipase A2 Inhibitors*/adverse effects, Adult ; Clinical Trials, Phase I as Topic ; Clinical Trials, Phase II as Topic ; Humans ; Randomized Controlled Trials as Topic ; Treatment Outcome

المؤلفون: Kugelberg, E., Norström, T., Petersen, T.K., Duvold, T., Andersson, D.I., Hughes, D.

المصدر: Antimicrob Agents Chemother.. 49(8):3435-41

وصف الملف: print

URL الوصول: https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-95823

المؤلفون: DE VENDITTIS, EMMANUELE, DE PAOLA B, GOGLIETTINO MA, ADINOLFI BS, FIENGO A, DUVOLD T, BOCCHINI V.

المساهمون: DE VENDITTIS, Emmanuele, DE PAOLA, B, Gogliettino, Ma, Adinolfi, B, Fiengo, A, Duvold, T, Bocchini, V.

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______3730::1d479751bdc6651933b2aeae647694b5
http://hdl.handle.net/11588/142725

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Roundy, Philip T., Asllani, Arben

المصدر: Industrial Management & Data Systems; 2024, Vol. 124 Issue 7, p2333-2363, 31p

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.